TREX1 mutations can mediate SLE-like pathological changes (57) with increased type I interferons, whereas the phenotypes of SLE in Trex1-/- mice depends on the activation of the cGAS-STING pathway (58). This evidence concerns the gene STING1 and systemic lupus erythematosus.